FDS · Factset Research Systems Inc
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | 220.17M | Q3 2026 | — |
|
|
|||
| Adjusted diluted EPS non-GAAP | $4.46 | Q2 fiscal 2026 | — |
GAAP → non-GAAP reconciliationGAAP Diluted EPS $3.59
+$0.41 Intangible asset amortization
+$0.28 Impairment within Other assets
+$0.08 CEO compensation costs
+$0.06 India labor codes reform
+$0.04 Business disposition, acquisitions and related costs
+$0.02 Asset impairment
+$0 Restructuring/severance
+$0 Non-operating income from business disposition
-$0.02 Income tax items
= Adjusted diluted EPS $4.46
|
|||
| Annual client retention | 91% | Q2 fiscal 2026 | — |
| Annual Subscription Value (ASV) | 2.45B | Q2 fiscal 2026 | — |
| ASV from Asia Pacific | 249.1M | Q2 fiscal 2026 | — |
| ASV from EMEA | 595.2M | Q2 fiscal 2026 | — |
| ASV from the Americas | 1.61B | Q2 fiscal 2026 | — |
| Client count | 9,101 | Q2 fiscal 2026 | — |
| Employee headcount | 12,840 | Q2 fiscal 2026 | — |
| Free cash flow non-GAAP | 185.7M | Q2 fiscal 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net Cash Provided for Operating Activities 211.69M
-26M Less: purchases of property, equipment, leasehold improvements and capitalized internal-use software
= Free Cash Flow 185.69M
|
|||
| Net increase in clients (last three months) | 98 | Q2 fiscal 2026 | — |
| Net increase in users (last three months) | 1,489 | Q2 fiscal 2026 | — |
| Organic ASV non-GAAP | 2.45B | Q2 fiscal 2026 | — |
GAAP → non-GAAP reconciliationGAAP As reported ASV 2.45B
-1.1M Impact from foreign currency movements
= Organic ASV 2.45B
|
|||
| Organic ASV from Asia Pacific non-GAAP | 249.1M | Q2 fiscal 2026 | — |
| Organic ASV from EMEA non-GAAP | 594.2M | Q2 fiscal 2026 | — |
| Organic ASV from the Americas non-GAAP | 1.61B | Q2 fiscal 2026 | — |
| Organic ASV growth (year over year) non-GAAP | 152.9M | Q2 fiscal 2026 | — |
| Remaining share repurchase authorization | 697.1M | Q2 fiscal 2026 | — |
| Shares repurchased | 651,750 | Q2 fiscal 2026 | — |
| User count | 241,352 | Q2 fiscal 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Financial Data & Stock Exchanges — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FDS
this stock
Factset Research Systems Inc
|
$10.59B | +2.7% | +6.3% | 19.6 | 11.1% |
|
SPGI
S&P Global Inc.
|
$124.70B | — | +7.1% | 26.7 | 2.8% |
|
CME
Cme Group Inc.
|
$97.33B | -2.2% | +6.4% | 23.0 | 1.7% |
|
ICE
Intercontinental Exchange, Inc.
|
$88.27B | -3.6% | -2.1% | 22.2 | 1.4% |
|
MCO
Moodys Corp /De/
|
$82.65B | -4.9% | +16.6% | 30.3 | 1.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FDS | +7.2% | +21.6% | +39.1% | +13.3% | +2.7% |
| SPY | -0.4% | +2.6% | +10.7% | +2.7% | +12.5% |
| vs SPY | +7.6% | +19.0% | +28.4% | +10.5% | -9.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.